APOTEX CORP. for APOTEX CORP.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 3962, the Affordable Healthcare For America Act, Title VII Medicaid and CHIP, Subtitle E, Financing, Section 1741, Payments to Pharmacists HR 3590, the Patient Protection and Affordable Care Act, Section 2503, Providing Adequate Pharmacy Reimbursement
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Pharmacy PHA
S 369, the Preserve Access to Affordable Pharmaceuticals Act HR 1706, the Protecting Consumer Access to Generic Drugs Act S. 1315, the Drug Price Competition Act of 2009 HR 3777, the Drug Price Competition Act of 2009 HR 3200, Subtitle C, Food & Drug Administration, Secrtion 2563, Protecting Consumer Access to Generic Drugs Act HR 3962, Affordable Health Care for America Act, Section 2573, Protecting Consumer Access to Generic Drugs Act, Section 2575, Lincensure Pathway for Biosimilar Products HR 3590, the Patient Protection and Affordable Care Act, Title VII, Subtitle A, Biologics Price Competition and Innovation
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.